Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection

Clinical trial NCT03597347 · TERMINATED

Trial details

NCT number: NCT03597347
Sponsor: Savara Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Mycobacterium Infections, Nontuberculous Cystic Fibrosis (CF)

Start date: 2019-06-20
Primary completion: 2020-10-02
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.